13 analysts have shared their evaluations of Synopsys SNPS during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 8 | 5 | 0 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 2 | 0 | 0 | 0 | 0 |
3M Ago | 5 | 5 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $622.31, with a high estimate of $675.00 and a low estimate of $550.00. Observing a 8.99% increase, the current average has risen from the previous average price target of $571.00.
Diving into Analyst Ratings: An In-Depth Exploration
The standing of Synopsys among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Blair Abernethy | Rosenblatt | Raises | Buy | $615.00 | $570.00 |
Charles Shi | Needham | Maintains | Buy | $660.00 | $660.00 |
Vivek Arya | B of A Securities | Maintains | Buy | $650.00 | $650.00 |
Gary Mobley | Wells Fargo | Raises | Overweight | $630.00 | $620.00 |
Blair Abernethy | Rosenblatt | Raises | Buy | $570.00 | $485.00 |
Joe Vruwink | Baird | Raises | Outperform | $590.00 | $506.00 |
Ruben Roy | Stifel | Raises | Buy | $620.00 | $550.00 |
Gary Mobley | Wells Fargo | Raises | Overweight | $620.00 | $600.00 |
Charles Shi | Needham | Raises | Buy | $660.00 | $500.00 |
Jason Celino | Keybanc | Raises | Overweight | $675.00 | $600.00 |
Vivek Arya | B of A Securities | Announces | Buy | $650.00 | - |
Ruben Roy | Stifel | Maintains | Buy | $550.00 | - |
Jason Celino | Keybanc | Raises | Overweight | $600.00 | $540.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Synopsys. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Synopsys compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
Capture valuable insights into Synopsys's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Synopsys analyst ratings.
Discovering Synopsys: A Closer Look
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Financial Milestones: Synopsys's Journey
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Positive Revenue Trend: Examining Synopsys's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 24.51% as of 31 October, 2023, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 21.84%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Synopsys's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 5.77%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Synopsys's ROA stands out, surpassing industry averages. With an impressive ROA of 3.45%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Synopsys's debt-to-equity ratio is below the industry average. With a ratio of 0.11, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
The Significance of Analyst Ratings Explained
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.